CBLN1 and hepatocellular carcinoma: Although the role of Cer/CerK axis in hepatocellular carcinoma (HCC) is unclear, a dysregulation of Cer metabolism has been reported in HCC progression [63, 64], in particular of Cer synthases and ceramidases.